Analyst Thinks Johnson & Johnson Could Hit a $280 Target
A major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
Why Price Weighting Matters In Indices describes why price-based indices react differently than value- or market-cap peers, with real-world examples.
26,390 articlesA major analyst raises the price target on Johnson & Johnson to $280, arguing growing oncology sales and a planned sp...
President Trump has granted a 60-day waiver of the Jones Act to accelerate energy shipments within U.S. waters, in a ...
Snowflake jumped roughly 9% in early trading, outpacing ServiceNow as investors chase AI-driven growth. The cloud sof...
Institutional investors are loading up on two beaten-down software giants as AI infrastructure demand remains solid a...
A wave of healthcare AI players trading under $50 is drawing attention for real progress in partnerships and revenue....
Pagaya Technologies posted stronger-than-expected Q1 results, raised full-year guidance, and trades below $14, presen...
Dogecoin has fallen under the 10-cent threshold amid a broad risk-off in crypto markets. With no single catalyst, tra...
A wave of AI demand and energy-cost pressures are reviving interest in crypto operators who pivot to AI compute. The ...
In 2026, you can build real passive income with smart, practical plans. This guide breaks down ideas that work, plus ...
Alphabet delivered margin expansion and robust cloud growth in the latest quarter, underscoring its cash-flow potenti...
AI fears roiled tech names, dragging CrowdStrike lower despite strong fundamentals. Analysts see a 40% upside as sent...
A once-prolific $1,000 strategy beat the market story has turned into a cautionary tale. New investors face sharp los...